Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy

(2012) Sadhak Sengupta et al.   Clinical & Developmental Immunology

The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior

(2012) Dongyong Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma

(2012) You Ling et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres — A review

(2012) Ashlee N. Ford Versypt et al.   JOURNAL OF CONTROLLED RELEASE

Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model

(2011) M. Verreault et al.   JOURNAL OF CONTROLLED RELEASE

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature

(2010) N. Gaspar et al.   CANCER RESEARCH

Gene expression profiling predicts response to temozolomide in malignant gliomas

(2010) Yoshino   INTERNATIONAL JOURNAL OF ONCOLOGY

Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice

(2009) Daniel Moreno et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

(2008) Karsten Ulbrich et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles

(2008) Einat Cohen-Sela et al.   JOURNAL OF CONTROLLED RELEASE

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE